Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

3.1K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.1K
Development of Blood Vessels01:07

Development of Blood Vessels

1.2K
The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vascular Endothelial Growth Factor-D Improves Lung Vascular Integrity During Acute Lung Injury.

Circulation research·2026
Same author

Budget impact model of acellular tissue engineered vessel for the repair of extremity arterial trauma when autologous vein is not feasible.

Journal of medical economics·2025
Same author

Rational engineering of lung alveolar epithelium.

NPJ Regenerative medicine·2023
Same author

SARS-CoV-2 leverages airway epithelial protective mechanism for viral infection.

bioRxiv : the preprint server for biology·2022
Same author

Single-cell connectomic analysis of adult mammalian lungs.

Science advances·2019
Same journal

A native sulfur deposit in Gale crater, Mars.

Science (New York, N.Y.)·2026
Same journal

Coordinated demise of harmful algal blooms.

Science (New York, N.Y.)·2026
Same journal

Genetic effects put into context.

Science (New York, N.Y.)·2026
Same journal

Bacteria share proteins to survive antibiotics.

Science (New York, N.Y.)·2026
Same journal

Impacts shaped Earth's first continents.

Science (New York, N.Y.)·2026
Same journal

Erratum for the Report "Covalently bonded single-molecule junctions with stable and reversible photoswitched conductivity" by C. Jia <i>et al</i>.

Science (New York, N.Y.)·2026
See all related articles

Related Experiment Video

Updated: Dec 6, 2025

Bioengineering Human Microvascular Networks in Immunodeficient Mice
06:55

Bioengineering Human Microvascular Networks in Immunodeficient Mice

Published on: July 11, 2011

12.6K

Bioengineered human blood vessels.

Laura E Niklason1,2, Jeffrey H Lawson3,4

  • 1Departments of Anesthesiology and Biomedical Engineering, Yale University, New Haven, CT, USA. laura.niklason@yale.edu lawson@humacyte.com.

Science (New York, N.Y.)
|October 9, 2020
PubMed
Summary
This summary is machine-generated.

Engineered human arteries, utilizing advances in connective tissue engineering, physiology, and biomanufacturing, are poised to revolutionize vascular disease treatment.

More Related Videos

Generation of Human Blood Vessel Organoids from Pluripotent Stem Cells
09:46

Generation of Human Blood Vessel Organoids from Pluripotent Stem Cells

Published on: January 20, 2023

7.5K
Scaling of Engineered Vascular Grafts Using 3D Printed Guides and the Ring Stacking Method
09:38

Scaling of Engineered Vascular Grafts Using 3D Printed Guides and the Ring Stacking Method

Published on: March 27, 2017

8.7K

Related Experiment Videos

Last Updated: Dec 6, 2025

Bioengineering Human Microvascular Networks in Immunodeficient Mice
06:55

Bioengineering Human Microvascular Networks in Immunodeficient Mice

Published on: July 11, 2011

12.6K
Generation of Human Blood Vessel Organoids from Pluripotent Stem Cells
09:46

Generation of Human Blood Vessel Organoids from Pluripotent Stem Cells

Published on: January 20, 2023

7.5K
Scaling of Engineered Vascular Grafts Using 3D Printed Guides and the Ring Stacking Method
09:38

Scaling of Engineered Vascular Grafts Using 3D Printed Guides and the Ring Stacking Method

Published on: March 27, 2017

8.7K

Area of Science:

  • Biomedical Engineering
  • Vascular Biology
  • Regenerative Medicine

Background:

  • Vascular anastomosis, pioneered by Alexis Carrel, has been crucial for treating vascular injuries and diseases.
  • Arterial grafts have evolved from early artificial materials to modern polymer fabrics.
  • Understanding of arterial physiology and cell biology has advanced significantly.

Purpose of the Study:

  • To highlight the progress and potential of engineered human arteries in surgical therapy.
  • To discuss the interdisciplinary advancements enabling the development of artificial arteries.
  • To position engineered arteries as a future mainstay for treating vascular disease.

Main Methods:

  • Leveraging recent advances in connective tissue engineering.
  • Integrating knowledge from physiology and cell biology.
  • Utilizing progress in biomanufacturing techniques.

Main Results:

  • Engineered human arteries are nearing clinical application.
  • Interdisciplinary progress has paved the way for artificial artery development.
  • These engineered vessels promise to be a significant therapeutic option.

Conclusions:

  • Engineered human arteries represent a major advancement in vascular surgery.
  • The convergence of multiple scientific fields is driving this innovation.
  • Artificial arteries are expected to become a standard treatment for vascular conditions.